PMID- 37577843
OWN - NLM
STAT- MEDLINE
DCOM- 20230905
LR  - 20231227
IS  - 1473-5687 (Electronic)
IS  - 0954-691X (Linking)
VI  - 35
IP  - 10
DP  - 2023 Oct 1
TI  - Hospital discharge after percutaneous liver biopsy - less is more?
PG  - 1186-1191
LID - 10.1097/MEG.0000000000002611 [doi]
AB  - INTRODUCTION: Liver biopsy is a technique frequently performed in clinical 
      practice. However, the recommended surveillance period after the procedure is not 
      established in the guidelines. The aim of this study was to assess the safety and 
      patient satisfaction of hospital discharge 2 h after a percutaneous liver biopsy. 
      METHODS: Prospective monocentric study which included all patients who underwent 
      percutaneous liver biopsy between December 2020 and November 2022. Individuals 
      were discharged 2 h after the procedure according to a protocol that was 
      implemented in our institution. RESULTS: A total of 200 patients were included, 
      the majority male (52.0%), with a median age of 52 years old (interquartile range 
      (IQR) 40-60). Forty-two (21.0%) individuals had mild adverse events at the time 
      of or within 2 h of the procedure. Most (90.4%) occurred in the first hour after 
      the liver biopsy. Only 5 (2.5%) patients were kept under observation for 4 h due 
      to abdominal/shoulder pain. There were no serious complications and no patient 
      required subsequent admission. The majority of patients reported being 
      satisfied/very satisfied (99.4%) and felt safe (98.9%) with this protocol. Most 
      of the individuals showed a preference for early hospital discharge (97.3%). 
      CONCLUSION: We showed that patients requiring percutaneous liver biopsy can be 
      safely discharged 2 h after the procedure.
CI  - Copyright (c) 2023 Wolters Kluwer Health, Inc. All rights reserved.
FAU - Garrido, Isabel
AU  - Garrido I
AD  - Gastroenterology and Hepatology Department, Centro Hospitalar Universitario de 
      Sao Joao, Porto, Portugal.
AD  - World Gastroenterology Organization (WGO) Porto Training Center, Porto, Portugal.
FAU - Coelho, Rosa
AU  - Coelho R
AD  - Gastroenterology and Hepatology Department, Centro Hospitalar Universitario de 
      Sao Joao, Porto, Portugal.
AD  - World Gastroenterology Organization (WGO) Porto Training Center, Porto, Portugal.
FAU - Macedo, Guilherme
AU  - Macedo G
AD  - Gastroenterology and Hepatology Department, Centro Hospitalar Universitario de 
      Sao Joao, Porto, Portugal.
AD  - World Gastroenterology Organization (WGO) Porto Training Center, Porto, Portugal.
LA  - eng
PT  - Journal Article
DEP - 20230711
PL  - England
TA  - Eur J Gastroenterol Hepatol
JT  - European journal of gastroenterology & hepatology
JID - 9000874
SB  - IM
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Patient Discharge
MH  - Prospective Studies
MH  - Biopsy/adverse effects
MH  - *Liver/pathology
MH  - Hospitals
EDAT- 2023/08/14 06:42
MHDA- 2023/09/05 06:42
CRDT- 2023/08/14 05:29
PHST- 2023/09/05 06:42 [medline]
PHST- 2023/08/14 06:42 [pubmed]
PHST- 2023/08/14 05:29 [entrez]
AID - 00042737-202310000-00016 [pii]
AID - 10.1097/MEG.0000000000002611 [doi]
PST - ppublish
SO  - Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1186-1191. doi: 
      10.1097/MEG.0000000000002611. Epub 2023 Jul 11.